# Curanex Pharmaceuticals Inc

> Alpha governed public record. Unknown, unavailable, and unpublished values are never inferred as zero.

## Record

| Field | Value |
| --- | --- |
| Representation | alpha-profile-markdown-v4 |
| Protocol | Alpha Governance Facts Protocol 0.1 |
| Schema | alpha.governance.entity.public.v1 |
| Record version | public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce |
| Governance record representation | alpha-governance-record-v2 |
| Canonical entity | alpha:company:8d2a8089-e3ee-460a-96b1-f53d6f48b513 |
| Entity type | Company |
| Canonical URL | https://registry.alpha.ac/companies/curanex-pharmaceuticals-inc |
| Publication | PUBLISHED |
| Verification | source_reported |
| Verification schema | alpha-verification-states-v1 |
| Ownership | unclaimed |
| Published claims | 10 |
| Claims under review | 1 |
| Evidence records | 7 |
| Conflicts | 0 |
| Conflicts in internal review | 0 |
| Observed | 2026-10-09T04:47:10.853015+00:00 |
| Last reviewed | 2026-10-09T04:47:10.853015+00:00 |

## Identity

- Legal name: Curanex Pharmaceuticals Inc
- Display name: Curanex Pharmaceuticals Inc

## Alpha Governance Record

| Field | Value |
| --- | --- |
| Governance Record schema | alpha-governance-record-v2 |
| Ontology | alpha-governance-ontology-v1 |
| Record version | public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce |
| As of | 2026-10-09T15:15:12.88466+00:00 |
| Completeness | 0.318 |
| Record Quality | 0.816 |
| Directors | 0 |
| Committees | 0 |
| Governance events | 6 |
| Entity class | public_company |

## Section coverage

| Section | State |
| --- | --- |
| identity | PUBLISHED |
| corporate_structure | NOT_REVIEWED |
| board | NOT_REVIEWED |
| committees | NOT_REVIEWED |
| leadership | PUBLISHED |
| ownership | NOT_REVIEWED |
| financials | NOT_REVIEWED |
| capital_structure | PUBLISHED |
| compensation | NOT_REVIEWED |
| governance | NOT_REVIEWED |
| shareholder_governance | NOT_REVIEWED |
| audit | NOT_REVIEWED |
| legal | NOT_REVIEWED |
| risk | NOT_REVIEWED |
| cyber | NOT_REVIEWED |
| ai_governance | NOT_REVIEWED |
| agent_governance | RESTRICTED |
| markets_external | NOT_REVIEWED |
| events | PUBLISHED |
| relationships | PUBLISHED |
| assessments | PUBLISHED |
| evidence | PUBLISHED |

## Executive leadership

- Dian Ying Jing: Secretary. Status: current. claim_id=alpha:claim:company:8d2a8089-e3ee-460a-96b1-f53d6f48b513:leadership_role:5
- Huijuan Zhong: Chief Scientific Officer and Director. Status: current. claim_id=alpha:claim:company:8d2a8089-e3ee-460a-96b1-f53d6f48b513:leadership_role:6
- Jun Liu: Chief Executive Officer, President, Chairman and Director [CEO]. Status: current. claim_id=alpha:claim:company:8d2a8089-e3ee-460a-96b1-f53d6f48b513:leadership_role:7
- Liqin Xie: Chief Operating Officer [COO]. Status: current. claim_id=alpha:claim:company:8d2a8089-e3ee-460a-96b1-f53d6f48b513:leadership_role:8
- Ning Zhang: Chief Technology Officer [CTO]. Status: current. claim_id=alpha:claim:company:8d2a8089-e3ee-460a-96b1-f53d6f48b513:leadership_role:9
- Wei Zhang: Chief Financial Officer and Treasurer [CFO]. Status: current. claim_id=alpha:claim:company:8d2a8089-e3ee-460a-96b1-f53d6f48b513:leadership_role:10

## Governance events

- EXECUTIVE_APPOINTED: Dian Ying Jing executive of Curanex Pharmaceuticals Inc, effective 2026-03-30. Effective: 2026-03-30. Detected: 2026-10-09T04:47:10.853015+00:00. event_id=alpha:event:transition:19ltkv212i93wu
- EXECUTIVE_APPOINTED: Huijuan Zhong executive of Curanex Pharmaceuticals Inc, effective 2026-03-30. Effective: 2026-03-30. Detected: 2026-10-09T04:47:10.853015+00:00. event_id=alpha:event:transition:lzpl3j16i8kpr
- CEO_CHANGED: Jun Liu executive of Curanex Pharmaceuticals Inc, effective 2026-03-30. Effective: 2026-03-30. Detected: 2026-10-09T04:47:10.853015+00:00. event_id=alpha:event:transition:3mb1uw87qwfu
- EXECUTIVE_APPOINTED: Liqin Xie executive of Curanex Pharmaceuticals Inc, effective 2026-03-30. Effective: 2026-03-30. Detected: 2026-10-09T04:47:10.853015+00:00. event_id=alpha:event:transition:q8ex861nqzj0q
- EXECUTIVE_APPOINTED: Ning Zhang executive of Curanex Pharmaceuticals Inc, effective 2026-03-30. Effective: 2026-03-30. Detected: 2026-10-09T04:47:10.853015+00:00. event_id=alpha:event:transition:qh0ijr11lxniv
- CFO_CHANGED: Wei Zhang executive of Curanex Pharmaceuticals Inc, effective 2026-03-30. Effective: 2026-03-30. Detected: 2026-10-09T04:47:10.853015+00:00. event_id=alpha:event:transition:1y9bkg5aay0th

## Scoped resources

- `alpha://company/curanex-pharmaceuticals-inc` (contract): https://registry.alpha.ac/api/public/companies/curanex-pharmaceuticals-inc?format=record
- `alpha://company/curanex-pharmaceuticals-inc/identity` (contract): https://registry.alpha.ac/api/public/companies/curanex-pharmaceuticals-inc?format=record&section=identity
- `alpha://company/curanex-pharmaceuticals-inc/corporate-structure` (contract): https://registry.alpha.ac/api/public/companies/curanex-pharmaceuticals-inc?format=record&section=corporate-structure
- `alpha://company/curanex-pharmaceuticals-inc/board` (contract): https://registry.alpha.ac/api/public/companies/curanex-pharmaceuticals-inc?format=record&section=board
- `alpha://company/curanex-pharmaceuticals-inc/committees` (contract): https://registry.alpha.ac/api/public/companies/curanex-pharmaceuticals-inc?format=record&section=committees
- `alpha://company/curanex-pharmaceuticals-inc/leadership` (contract): https://registry.alpha.ac/api/public/companies/curanex-pharmaceuticals-inc?format=record&section=leadership
- `alpha://company/curanex-pharmaceuticals-inc/ownership` (contract): https://registry.alpha.ac/api/public/companies/curanex-pharmaceuticals-inc?format=record&section=ownership
- `alpha://company/curanex-pharmaceuticals-inc/financials` (contract): https://registry.alpha.ac/api/public/companies/curanex-pharmaceuticals-inc?format=record&section=financials
- `alpha://company/curanex-pharmaceuticals-inc/capital-structure` (contract): https://registry.alpha.ac/api/public/companies/curanex-pharmaceuticals-inc?format=record&section=capital-structure
- `alpha://company/curanex-pharmaceuticals-inc/compensation` (contract): https://registry.alpha.ac/api/public/companies/curanex-pharmaceuticals-inc?format=record&section=compensation
- `alpha://company/curanex-pharmaceuticals-inc/governance` (contract): https://registry.alpha.ac/api/public/companies/curanex-pharmaceuticals-inc?format=record&section=governance
- `alpha://company/curanex-pharmaceuticals-inc/shareholder-governance` (contract): https://registry.alpha.ac/api/public/companies/curanex-pharmaceuticals-inc?format=record&section=shareholder-governance
- `alpha://company/curanex-pharmaceuticals-inc/audit` (contract): https://registry.alpha.ac/api/public/companies/curanex-pharmaceuticals-inc?format=record&section=audit
- `alpha://company/curanex-pharmaceuticals-inc/legal` (contract): https://registry.alpha.ac/api/public/companies/curanex-pharmaceuticals-inc?format=record&section=legal
- `alpha://company/curanex-pharmaceuticals-inc/risk` (contract): https://registry.alpha.ac/api/public/companies/curanex-pharmaceuticals-inc?format=record&section=risk
- `alpha://company/curanex-pharmaceuticals-inc/cyber` (contract): https://registry.alpha.ac/api/public/companies/curanex-pharmaceuticals-inc?format=record&section=cyber
- `alpha://company/curanex-pharmaceuticals-inc/ai-governance` (contract): https://registry.alpha.ac/api/public/companies/curanex-pharmaceuticals-inc?format=record&section=ai-governance
- `alpha://company/curanex-pharmaceuticals-inc/agents` (contract): https://registry.alpha.ac/api/public/companies/curanex-pharmaceuticals-inc?format=record&section=agents
- `alpha://company/curanex-pharmaceuticals-inc/ecosystem` (contract): https://registry.alpha.ac/api/public/companies/curanex-pharmaceuticals-inc?format=record&section=ecosystem
- `alpha://company/curanex-pharmaceuticals-inc/events` (contract): https://registry.alpha.ac/api/public/companies/curanex-pharmaceuticals-inc?format=record&section=events
- `alpha://company/curanex-pharmaceuticals-inc/relationships` (contract): https://registry.alpha.ac/api/public/companies/curanex-pharmaceuticals-inc?format=record&section=relationships
- `alpha://company/curanex-pharmaceuticals-inc/assessments` (contract): https://registry.alpha.ac/api/public/companies/curanex-pharmaceuticals-inc?format=record&section=assessments
- `alpha://company/curanex-pharmaceuticals-inc/evidence` (contract): https://registry.alpha.ac/api/public/companies/curanex-pharmaceuticals-inc?format=record&section=evidence

## Role modules

- NOT_ASSERTED

## Attention

- NO_RECORDS_FOUND

## Committee data

- NO_RECORDS_FOUND

## Leadership

- Dian Ying Jing: Secretary. Claim: alpha:claim:company:8d2a8089-e3ee-460a-96b1-f53d6f48b513:leadership_role:5. Valid from: 2026-03-30. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:400f0a0825322eb09b7ac542242a5a56fb3adfbb7c973c42960f8cee33f7e936.
- Huijuan Zhong: Chief Scientific Officer and Director. Claim: alpha:claim:company:8d2a8089-e3ee-460a-96b1-f53d6f48b513:leadership_role:6. Valid from: 2026-03-30. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:77a71d3af18c6a6d030e487618d7a3e5d72cfaf580d95cad3acd73d2a7d106f0.
- Jun Liu: Chief Executive Officer, President, Chairman and Director. Claim: alpha:claim:company:8d2a8089-e3ee-460a-96b1-f53d6f48b513:leadership_role:7. Valid from: 2026-03-30. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:5a614e2f961700860337a93ac7669c1ab52991c49fe38d67c2ae1952bf08d044.
- Liqin Xie: Chief Operating Officer. Claim: alpha:claim:company:8d2a8089-e3ee-460a-96b1-f53d6f48b513:leadership_role:8. Valid from: 2026-03-30. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:732c52f325b9f9aedb826a311ac52b8cd9b460a320400f873df4bebbc69ed3fb.
- Ning Zhang: Chief Technology Officer. Claim: alpha:claim:company:8d2a8089-e3ee-460a-96b1-f53d6f48b513:leadership_role:9. Valid from: 2026-03-30. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:a374da795a9affb48a90201111da64c67cc8ef059112ffa76eb7ba70a7e0f946.
- Wei Zhang: Chief Financial Officer and Treasurer. Claim: alpha:claim:company:8d2a8089-e3ee-460a-96b1-f53d6f48b513:leadership_role:10. Valid from: 2026-03-30. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:90ac97a419983bd8ea2cafda975619c264d06b843a2d0affb85ffef4760caee5.

## Roles

- PUBLISHED

## Governance

- NOT_ASSERTED

## Board committees

- NOT_ASSERTED

## Financials

- NOT_ASSERTED

## Workforce

- NOT_ASSERTED

## Market and index context

- PUBLISHED

## Legal Name

- Curanex Pharmaceuticals Inc. Claim: alpha:claim:company:8d2a8089-e3ee-460a-96b1-f53d6f48b513:legal_name:1. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:26c60b5232ea02687de7fe49d30ddfe32fd8a20438462f682ee0ef91e56ae2e3.

## Entity Status

- Public listing published. Claim: alpha:claim:company:8d2a8089-e3ee-460a-96b1-f53d6f48b513:entity_status:3. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:26c60b5232ea02687de7fe49d30ddfe32fd8a20438462f682ee0ef91e56ae2e3.

## Published Fact

- US. Claim: alpha:claim:company:8d2a8089-e3ee-460a-96b1-f53d6f48b513:published_fact:4. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:26c60b5232ea02687de7fe49d30ddfe32fd8a20438462f682ee0ef91e56ae2e3.

## Security Listing

- CURX (NASDAQ). Claim: alpha:claim:company:8d2a8089-e3ee-460a-96b1-f53d6f48b513:security_listing:11. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:26c60b5232ea02687de7fe49d30ddfe32fd8a20438462f682ee0ef91e56ae2e3.

## Coverage states

| Field | Value |
| --- | --- |
| Identity | PUBLISHED |
| Business | PUBLISHED |
| Leadership | PUBLISHED |
| Board and committees | NOT_ASSERTED |
| Governance | NOT_ASSERTED |
| Financials | NOT_ASSERTED |
| Workforce | NOT_ASSERTED |
| Ownership | NOT_ASSERTED |
| Ratings | NOT_PUBLISHED |
| Market and index context | PUBLISHED |

## Public sources

- alpha:projection-evidence:26c60b5232ea02687de7fe49d30ddfe32fd8a20438462f682ee0ef91e56ae2e3: [Alpha canonical company public projection](https://www.alpha.ac/api/public/companies/curanex-pharmaceuticals-inc).
- alpha:projection-evidence:document:400f0a0825322eb09b7ac542242a5a56fb3adfbb7c973c42960f8cee33f7e936: [CURX 10-K executive officers](https://www.sec.gov/Archives/edgar/data/2025942/000149315226013677/form10-k.htm).
- alpha:projection-evidence:document:77a71d3af18c6a6d030e487618d7a3e5d72cfaf580d95cad3acd73d2a7d106f0: [CURX 10-K executive officers](https://www.sec.gov/Archives/edgar/data/2025942/000149315226013677/form10-k.htm).
- alpha:projection-evidence:document:5a614e2f961700860337a93ac7669c1ab52991c49fe38d67c2ae1952bf08d044: [CURX 10-K executive officers](https://www.sec.gov/Archives/edgar/data/2025942/000149315226013677/form10-k.htm).
- alpha:projection-evidence:document:732c52f325b9f9aedb826a311ac52b8cd9b460a320400f873df4bebbc69ed3fb: [CURX 10-K executive officers](https://www.sec.gov/Archives/edgar/data/2025942/000149315226013677/form10-k.htm).
- alpha:projection-evidence:document:a374da795a9affb48a90201111da64c67cc8ef059112ffa76eb7ba70a7e0f946: [CURX 10-K executive officers](https://www.sec.gov/Archives/edgar/data/2025942/000149315226013677/form10-k.htm).
- alpha:projection-evidence:document:90ac97a419983bd8ea2cafda975619c264d06b843a2d0affb85ffef4760caee5: [CURX 10-K executive officers](https://www.sec.gov/Archives/edgar/data/2025942/000149315226013677/form10-k.htm).

## Rights

| Field | Value |
| --- | --- |
| public_retrieval | allowed |
| agent_retrieval | allowed |
| redistribution | not_granted |
| model_training | not_granted |
| commercial_use | not_specified |
| relationship_pathfinding | not_granted |
| direct_contact | not_granted |

## Limitations

- Absence of a leadership role, committee, or disclosure is not evidence that it does not exist.
- Only explicitly published canonical company identity and current confirmed public roles are included.
- Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.
- Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.
- This Company Profile is an identity and evidence record, not an Alpha rating.

## Alternate representations

- [Canonical profile](https://registry.alpha.ac/companies/curanex-pharmaceuticals-inc)
- [Public Markdown](https://registry.alpha.ac/companies/curanex-pharmaceuticals-inc.md)
- [Public JSON](https://registry.alpha.ac/api/public/companies/curanex-pharmaceuticals-inc?format=record)
- [JSON-LD](https://registry.alpha.ac/api/public/companies/curanex-pharmaceuticals-inc?format=jsonld)
- MCP resource: `alpha://companies/curanex-pharmaceuticals-inc` at https://mcp.alpha.ac/mcp


## Connected governance records

Only explicitly published, rights-cleared records. Missing records do not establish absence, safety, or complete coverage.

## Critical-risk oversight

Snapshot as of 2026-10-09T15:15:12.912542+00:00; recorded 2026-10-09T15:15:12.912542+00:00. Every published assignment for this snapshot is listed.
Only explicitly reviewed, rights-cleared assignments in effect on the as-of date, in the company's own wording.
An assignment shows where oversight is placed, not whether it is effective. Missing records do not establish absence.